Treatment Related Adverse Events in Urothelial Carcinoma WEBINAR

Registrations No Longer Being Accepted

Faculty: Peter H. O’Donnell, MD & Shilpa Gupta, MD Educational Grant Support: Seagen, Astellas and Merck

Joint Providers: Medical Education Resources and Enquiring Minds, LLC

Released on: September 12, 2022 Expires on: September 12, 2022 Media Type: internet Completion Time: 1 hour

Credit Available

Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)TM

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of physicians and other healthcare professionals involved in the care of urothelial carcinoma.

Program Overview

This interactive case-based activity requires clinicians to make real-world decisions as they optimize diagnostic and therapeutic strategies for patients with advanced urothelial carcinoma.

Throughout the activity practitioners will have the opportunity to immediately implement expert guidance and evaluate performance while addressing challenging questions about the latest clinical data and evidence-based recommendations.

Learning Objectives

Upon completion of this activity, participants should be better able to:

• Discuss the latest clinical evidence and guidance for treating advanced and metastatic urothelial carcinoma, including the clinical utility, safety-efficacy profiles and target patient populations for current and emerging therapies

• Individualize disease management decisions for patients with urothelial carcinoma, taking into consideration personal and clinical factors that may influence therapeutic efficacy

• Recommend evidence-based tactics for identifying, mitigating and managing treatment-related adverse events in a timely and effective manner

Faculty

Peter H. O’Donnell, MD

Associate Professor of Medicine

Hematology and Oncology

University of Chicago Medicine

Director, Genitourinary Oncology Program

University of Chicago Medical Center

Chicago, IL

Shilpa Gupta, MD

Associate Professor

Co-Leader, Genitourinary Oncology Program

Cleveland Clinic

Director, Genitourinary Oncology Program

Cleveland Clinic Taussig Cancer Institute

Cleveland, OH

Joint Accreditation Statement

Physician Credit Designation

Medical Education Resources designates this live activity for a maximum of 1.0 AMA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Disclosures of Conflicts of Interest

Medical Education Resources insures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported conflicts of interest are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Peter H. O’Donnell

Other Relationships: Janssen, Nektar, NIH, Dragonfly Therapeutics, G1 Therapeutics
Ownership Interest: Allergan

Shilpa Gupta, MD

Consulting Fees: Merck, Seattle Genetics, Bayer, Natera, Loxo Oncology, Gilead Biosciences
Speakers’ Bureau: Seattle Genetics, Gilead Biosciences

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

The MER planners and others have nothing to disclose. The Enquiring Minds, LLC planners and others have nothing to disclose

Instructions for Participation and Credit

There are no fees for participating and receiving credit for this live activity. During the period July 8, 2022 through July 8, 2022, participants must:

1. Read the learning objectives and faculty disclosures.

2. Participate in the online activity.

3. Complete the evaluation form.

A statement of credit will be issued only upon receipt of a completed activity evaluation form. Certificates will be emailed to the participant.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent

the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Enquiring Minds, LLC, Seagen and/or Merck. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Fee Information

There is no fee for this educational activity.

Contact Information

For CME questions please contact: 800-421-3756

Privacy Policy http://cmepartner.org/privacy

Medical Education Resources and Enquiring Minds, LLC maintain high standards for the protection of privacy over the Internet. The purpose of this statement is to explain what information we obtain, how it is used, and how visitors can restrict its use or disclosure.